Executive Summary of the 2019 International Conference of Korean Dementia Association: Exploring the Novel Concept of Alzheimer's Disease and Other Dementia: a Report from the Academic Committee of the Korean Dementia Association

키워드

참고문헌 (39)

1. McKhann G, "Clinical diagnosis of Alzheimer's disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease", Neurology, 34, pp.939~944 (1984)
2. Jack CR Jr, "NIA-AA Research Framework : toward a biological definition of Alzheimer's disease", Alzheimers Dement, 14, pp.535~562 (2018)
3. Jack CR Jr, "A", T, Neurology, pp.2016, 87[DOI]
4. Jack CR Jr, "Biomarker modeling of Alzheimer's disease", Neuron, 80, pp.1347~1358 (2013)
5. Jack CR Jr, "Tracking pathophysiological processes in Alzheimer's disease : an updated hypothetical model of dynamic biomarkers", Lancet Neurol, 12, pp.207~216 (2013)
6. Jack CR Jr, "Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade", Lancet Neurol, 9, pp.119~128 (2010)
7. Jagust W, "Imaging the evolution and pathophysiology of Alzheimer disease", Nat Rev Neurosci, 19, pp.687~700 (2018)
8. Donohue MC, "Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons", JAMA, 317, pp.2305~2316 (2017)
9. Dubois B, "Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease(INSIGHT-preAD) : a longitudinal observational study", Lancet Neurol, 17, pp.335~346 (2018)
10. Adams JN, "Relationships between tau and glucose metabolism reflect Alzheimer's disease pathology in cognitively normal older adults", Cereb Cortex, 29, pp.1997~2009 (2019)
11. Tosun D, "Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals", Brain, 140, pp.1499~1512 (2017)
12. Harrison TM, "Longitudinal tau accumulation and atrophy in aging and Alzheimer disease", Ann Neurol, 85, pp.229~240 (2019)
13. Bejanin A, "Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease", Brain, 140, pp.3286~3300 (2017)
14. Maass A, "Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging", J Neurosci, 38, pp.530~543 (2018)
15. Shi Q, "Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP", PS1 mice, 2017, pp.9, eaaf6295~
16. 김승현, "A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation", Dementia and Neurocognitive Disorders(대한치매학회지), 18(2), pp.33~46 (2019), 대한치매학회[DOI]
17. Guerreiro R, "TREM2 variants in Alzheimer's disease", N Engl J Med, 368, pp.117~127 (2013)
18. Jonsson T, "Variant of TREM2 associated with the risk of Alzheimer's disease", N Engl J Med, 368, pp.107~116 (2013)
19. Neumann H, "Variant TREM2 as risk factor for Alzheimer's disease", N Engl J Med, 368, pp.182~184 (2013)
20. Wang MJ, "Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease", Alzheimers Res Ther, 9, pp.98~ (2017)
21. Yoo YK, "A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease", Sci Rep, 7, pp.8882~ (2017)
22. Park JC, "Plasma tau", amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease, 2019, pp.142, 771~786
23. Kunkle BW, "Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing", Nat Genet, 51, pp.414~430 (2019)
24. Bis JC, "Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation", Mol Psychiatry (2018)
25. Zhang X, "A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease", Alzheimers Dement, 15, pp.441~452 (2019)
26. Patel D, "Association of rare coding mutations with Alzheimer disease and other dementias among adults of European ancestry", JAMA Netw Open, 2, pp.e191350~ (2019)
27. Rovelet-Lecrux A, "Frontotemporal dementia phenotype associated with MAPT gene duplication", J Alzheimers Dis, 21, pp.897~902 (2010)
28. Rovelet-Lecrux A, "APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy", Nat Genet, 38, pp.24~26 (2006)
29. Singleton AB, "α-Synuclein locus triplication causes Parkinson's disease", Science, 302, pp.841~ (2003)
30. Jones L, "Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease", PLoS One, 5, pp.e13950~ (2010)
31. Lambert JC, "Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease", Nat Genet, 45, pp.1452~1458 (2013)
32. Matarin M, "A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology", Cell Reports, 10, pp.633~644 (2015)
33. Mazzulli JR, "Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies", Cell, 146, pp.37~52 (2011)
34. Robak LA, "Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease", Brain, 140, pp.3191~3203 (2017)
35. Sidransky E, "Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease", N Engl J Med, 361, pp.1651~1661 (2009)
36. Jabbari E, "Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype", Ann Neurol, 84, pp.485~496 (2018)
37. Myeku N, "Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling", Nat Med, 22, pp.46~53 (2016)
38. Iwatsubo T, "Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies : harmonization for international trials", Alzheimers Dement, 14, pp.1077~1087 (2018)
39. Konno T, "CSF1R-related leukoencephalopathy : a major player in primary microgliopathies", Neurology, 91, pp.1092~1104 (2018)

관련 논문AI추천